Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-08

Clinical Trial Update: Roflumilast Plus Montelukast in Adults With Severe Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating roflumilast in combination with montelukast for adults with severe asthma has completed, with results posted in July 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)
  • SINGULAIR (montelukast)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-07-08